The research reveals how MiR-155 impacts T cell effectiveness in EBV+ gastric cancers, suggesting a mechanism for immune evasion.
, along with ICOSL status determines whether tumors attract T cells and whether those T cells can effectively eradicate cancer cells.
No takes yet. Share an insight, caveat, or question.
Nuovo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: